PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 46 filers reported holding PROFOUND MED CORP in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,099,000 | -21.4% | 401,833 | +0.3% | 0.00% | 0.0% |
Q2 2023 | $5,213,000 | +39.9% | 400,680 | -0.1% | 0.00% | 0.0% |
Q1 2023 | $3,725,000 | -14.4% | 400,994 | +0.3% | 0.00% | 0.0% |
Q4 2022 | $4,352,000 | +178.6% | 399,620 | +3.4% | 0.00% | – |
Q3 2022 | $1,562,000 | -44.6% | 386,620 | -0.1% | 0.00% | -100.0% |
Q2 2022 | $2,821,000 | -2.6% | 387,006 | +20.3% | 0.00% | 0.0% |
Q1 2022 | $2,896,000 | -1.5% | 321,701 | +22.9% | 0.00% | 0.0% |
Q4 2021 | $2,939,000 | -20.6% | 261,703 | +3.5% | 0.00% | 0.0% |
Q3 2021 | $3,701,000 | -10.2% | 252,776 | +0.3% | 0.00% | 0.0% |
Q2 2021 | $4,121,000 | +3277.9% | 251,930 | +4043.6% | 0.00% | – |
Q1 2021 | $122,000 | -28.7% | 6,080 | -26.9% | 0.00% | – |
Q4 2020 | $171,000 | +66.0% | 8,314 | +41.9% | 0.00% | – |
Q3 2020 | $103,000 | +10.8% | 5,861 | +6.7% | 0.00% | – |
Q2 2020 | $93,000 | +116.3% | 5,495 | +26.2% | 0.00% | – |
Q1 2020 | $43,000 | +7.5% | 4,354 | +17.7% | 0.00% | – |
Q4 2019 | $40,000 | – | 3,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 196,924 | $3,474,000 | 8.11% |
Gagnon Advisors, LLC | 277,252 | $4,891,000 | 3.00% |
GAGNON SECURITIES LLC | 779,533 | $13,751,000 | 2.93% |
Taylor Wealth Management Partners | 166,364 | $2,935,000 | 1.34% |
AWM Investment Company, Inc. | 348,939 | $6,155,000 | 1.01% |
PCJ Investment Counsel Ltd. | 121,560 | $2,137,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 780,567 | $13,769,000 | 0.71% |
Parkman Healthcare Partners LLC | 70,000 | $1,235,000 | 0.33% |
Park West Asset Management LLC | 450,000 | $7,938,000 | 0.31% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 695,000 | $12,260,000 | 0.30% |